what is considered a low dose of tirzepatide Dosing Tirzepatide Dosing for Weight Loss

Lancet Diabetes Endocrinol 2022;10:634644

Safety, Side Effects, and Who Should Not Use GLP-1 Medications GLP-1 medications are prescription drugs with real physiological effects

About 82% of people on tirzepatide achieved at least 5% weight loss, versus 67% on semaglutide

Semaglutide pens (Ozempic) allow up to 56 days at room temperature, significantly longer than tirzepatide at 21 days

Weight-loss medications reduce overall body fat, while CoolSculpting targets stubborn, localized fat

For weight loss purposes, these medications are not recommended during pregnancy, and tirzepatide should be discontinued at least 1 month before planned conception due to its long half-life